| | | | | | | | | | |
|
|
| Dockets Entered
On August 2, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
| 1987C-0023
|
| SAFE USE OF CARBON BLACK FOR COLORING COSMETICS
|
|
|
| 1994P-0390
|
| Adopt Amendments Governing Health Claims & Nutrient Claims
|
|
|
| 1995P-0241
|
| Implied Nutrient Content Claim 'Healthy' & Health Claims
|
|
|
| 1997N-0497
|
| Allogeneic Peripheral and Placental/ Umbilical Cord Blood
|
|
|
| 1997S-0163
|
| Dietary Supplements, Courtesy Letters (Letters of Objection)
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutritin
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 1999P-5106
|
| Identify Sources of Natural Flavorings
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2002E-0342
|
| Lea's Shield, U.S. Patent No. 4,703,752
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2002P-0499
|
| ANDA Suitability for Metformin Hydrochloride Tablets Oral So
|
|
|
| 2003D-0558
|
| Guidance Levels for Radionuclides in Domestic and Imported Foods
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| 2003N-0169
|
| Dental Amalgam; Request for Information
|
|
|
| 2003P-0574
|
| Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
|
|
|
| 2004N-0018
|
| Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application
|
|
|
| 2004N-0081
|
| BSE Risk Materials in Foods and Cosmetics
|
|
|
| 2004N-0159
|
| Schering Corp. et al.; Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications
|
|
|
| 2004N-0181
|
| Critical Path Initiative
|
|
|
| 2004N-0184
|
| Requirements Pertaining to Sampling and Private Laboratories Used in Connection With Importing Food
|
|
|
| 2004N-0258
|
| Produce Safety from Production to Consumption: An Action Plan to Minimize Foodborne Illness Associated with Fresh Produce
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
| 2004P-0051
|
| Dyclone (dyclonine hydrochloride) Topical Solution 0.5% and 1.0% (NDA 9-925) was voluntarily withdrawn or withheld from sale for reasons other then safety or efficacy
|
|
|
| 1987C-0023
|
| SAFE USE OF CARBON BLACK FOR COLORING COSMETICS
|
|
|
| EA
1
|
| Revised environmental Assiessment for Color Additive Petition 7C0208
|
| Vol #:
|
| 1
|
|
|
| FONS
1
|
| Finding of No significant Impact for Color Additive Petition 7C0208
|
| Vol #:
|
| 1
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 1994P-0390
|
| Adopt Amendments Governing Health Claims & Nutrient Claims
|
|
|
| C
66
|
| Federal Trade Commission (FTC)
|
| Vol #:
|
| 7
|
|
|
| 1995P-0241
|
| Implied Nutrient Content Claim 'Healthy' & Health Claims
|
|
|
| C
83
|
| Federal Trade Commission (FTC)
|
| Vol #:
|
| 9
|
|
|
| 1997N-0497
|
| Allogeneic Peripheral and Placental/ Umbilical Cord Blood
|
|
| | | | | | | | |
|
|
| EMC 9954
|
| B. Anderson
|
| Vol #:
|
| 286
|
|
|
| EMC 9955
|
| J. Brown
|
| Vol #:
|
| 286
|
|
|
| EMC 9956
|
| P. G. Buck
|
| Vol #:
|
| 286
|
|
|
| EMC 9957
|
| C. DeToma
|
| Vol #:
|
| 286
|
|
|
| EMC 9958
|
| J. Kahn
|
| Vol #:
|
| 286
|
|
|
| EMC 9959
|
| J. Davidson
|
| Vol #:
|
| 286
|
|
|
| EMC 9960
|
| K. Hoerl
|
| Vol #:
|
| 286
|
|
|
| 2002E-0342
|
| Lea's Shield, U.S. Patent No. 4,703,752
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC
352
|
| Mission Possible International
|
| Vol #:
|
| 6
|
|
|
| 2002P-0499
|
| ANDA Suitability for Metformin Hydrochloride Tablets Oral So
|
|
|
| LET
2
|
| HFD-600 to The Weinberg Group Inc
|
| Vol #:
|
| 1
|
|
|
| 2003D-0558
|
| Guidance Levels for Radionuclides in Domestic and Imported Foods
|
|
|
| BKG
2
|
| Supporting Document for Guidance Levels for Radionuclides in Domestic and Imported Foods
|
| Vol #:
|
| 1
|
|
|
| GDL
2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| EMC 320
|
| M. Leckey
|
| Vol #:
|
| 8
|
|
|
| EMC 321
|
| J. Baxter
|
| Vol #:
|
| 8
|
|
|
| 2003N-0169
|
| Dental Amalgam; Request for Information
|
|
|
| EMC
237
|
| Power in Numbers, Inc.
|
| Vol #:
|
| 6
|
|
|
| EMC
238
|
| Consumers for Dental Choice
|
| Vol #:
|
| 6
|
|
|
| EMC 239
|
| M. Rygg
|
| Vol #:
|
| 6
|
|
|
| EMC 240
|
| M. Rygg
|
| Vol #:
|
| 6
|
|
|
| 2003P-0574
|
| Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
|
|
|
| C
2
|
| Wisconsin Dairy Products Assn, Inc.
|
| Vol #:
|
| 2
|
|
|
| 2004N-0018
|
| Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application
|
|
|
| EMC 1
|
| R. Pickering, PhD., RN
|
| Vol #:
|
| 1
|
|
|
| 2004N-0081
|
| BSE Risk Materials in Foods and Cosmetics
|
|
|
| C
3
|
| S Foods, Inc.
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2004N-0159
|
| Schering Corp. et al.; Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications
|
|
|
| NCR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0181
|
| Critical Path Initiative
|
|
|
| C
15
|
| American Society of Gene Therapy
|
| Vol #:
|
| 1
|
|
|
| C
16
|
| Cook Group, Inc. (Cook)
|
| Vol #:
|
| 1
|
|
|
| C 17
|
| M. Magrine
|
| Vol #:
|
| 1
|
|
|
| C 18
|
| M. Magrine
|
| Vol #:
|
| 1
|
|
|
| C
19
|
| Society for Women's Health Research
|
| Vol #:
|
| 1
|
|
|
| C
20
References
|
| Susan Eik Filstead Stroke & Epilepsy Foundation, Inc.
|
| Vol #:
|
| 1
|
|
|
| C
21
|
| National Electrical Manufacturers Assn (NEMA)
|
| Vol #:
|
| 1
|
|
|
| C 22
|
| A. and T. Healey
|
| Vol #:
|
| 1
|
|
|
| C 23
|
| S. Kelly
|
| Vol #:
|
| 1
|
|
|
| C 24
|
| R. Alter
|
| Vol #:
|
| 1
|
|
|
| C 25
|
| S. Gaumond
|
| Vol #:
|
| 1
|
|
|
| C
26
|
| Baxter International, Inc. (Baxter)
|
| Vol #:
|
| 1
|
|
|
| C
27
|
| Pharmaco-Diagnostics (Rx-Dx) Partnerships Program
|
| Vol #:
|
| 1
|
|
|
| C
28
|
| California Healthcare Institute
|
| Vol #:
|
| 1
|
|
|
| C
29
|
| Advanced Medical Technology Assn (AdvaMed)
|
| Vol #:
|
| 1
|
|
|
| C
30
|
| FasterCures
|
| Vol #:
|
| 1
|
|
|
| C
31
|
| Novartis Pharmaceuticals Corp.
|
| Vol #:
|
| 2
|
|
|
| C 32
|
| J and S Healey
|
| Vol #:
|
| 2
|
|
|
| C
33
|
| International Foundation for Functional Gastrointestinal Disorders
|
| Vol #:
|
| 2
|
|
|
| C
34
|
| Assn of American Medical Colleges (AAMC)
|
| Vol #:
|
| 2
|
|
|
| C
35
|
| National Osteoporosis Foundation(NOF) and American Society for Bone and Mineral Resaearch (ASB
|
| Vol #:
|
| 2
|
|
|
| EC 7
|
| Mrs. Debra Wildrick
|
| Vol #:
|
| 2
|
|
|
| EC 8
|
| National Electrical Manufacturers Association
|
| Vol #:
|
| 2
|
|
|
| EC 9
|
| ProSanos Corporation
|
| Vol #:
|
| 2
|
|
|
| EC 10
|
| IFFGD
|
| Vol #:
|
| 2
|
|
|
| EC
11
Attachments
|
| invivodata, inc.
|
| Vol #:
|
| 2
|
|
|
| EC
12
|
| Cystic Fibrosis Foundation
|
| Vol #:
|
| 2
|
|
|
| EC 13
|
| Cystic Fibrosis Foundation
|
| Vol #:
|
| 2
|
|
|
| EC 14
|
| Cystic Fibrosis
|
| Vol #:
|
| 2
|
|
|
| EC 15
|
| Alliance for Aging Research
|
| Vol #:
|
| 2
|
|
|
| EC 16
|
| University of Wisconsin School of Pharmacy
|
| Vol #:
|
| 2
|
|
|
| EC 17
|
| Elsevier
|
| Vol #:
|
| 2
|
|
|
| EC 18
|
| ECRI
|
| Vol #:
|
| 2
|
|
| | | | | | | | |
|
|
| EC 19
|
| United States Bone and Joint Decade, NFP
|
| Vol #:
|
| 2
|
|
|
| EC
20
Attachment
|
| National Health Council
|
| Vol #:
|
| 2
|
|
|
| EC
21
Attachment
|
| Medical Device Manufacturers Association
|
| Vol #:
|
| 2
|
|
|
| EC 22
|
| Targacept, Inc.
|
| Vol #:
|
| 2
|
|
|
| EC 23
|
| AIDS Treatment Activist Coalition
|
| Vol #:
|
| 2
|
|
|
| EC 24
|
| Alzheimer's Association
|
| Vol #:
|
| 2
|
|
|
| EC 25
|
| PBG Consulting
|
| Vol #:
|
| 2
|
|
|
| EC
26
Attachment
|
| PBG Consulting
|
| Vol #:
|
| 2
|
|
|
| EC 27
|
| National Osteoporosis Foundation
|
| Vol #:
|
| 2
|
|
|
| EC
28
|
| ASCO
|
| Vol #:
|
| 2
|
|
|
| EC
29
Attachment 1, 2
|
| Parkinson Pipeline Project
|
| Vol #:
|
| 2
|
|
|
| EC
30
|
| National Osteoporosis Foundation
|
| Vol #:
|
| 2
|
|
|
| EC 31
|
| National Osteoporosis
|
| Vol #:
|
| 2
|
|
|
| EC
32
Attachment
|
| PBG Consulting
|
| Vol #:
|
| 2
|
|
|
| EC
33
Attachment
|
| The ALS Association
|
| Vol #:
|
| 2
|
|
|
| EC
34
|
| Prostate Cancer Foundation
|
| Vol #:
|
| 2
|
|
|
| EC 35
|
| Prostate Cancer Foundation
|
| Vol #:
|
| 2
|
|
|
| EC 36
|
| Prostate Cancer Foundation
|
| Vol #:
|
| 2
|
|
|
| EC
37
|
| Pancreatic Cancer Action Network
|
| Vol #:
|
| 2
|
|
|
| EC 38
|
| Battelle
|
| Vol #:
|
| 2
|
|
|
| EC 39
|
| Targacept, Inc.
|
| Vol #:
|
| 2
|
|
|
| 2004N-0184
|
| Requirements Pertaining to Sampling and Private Laboratories Used in Connection With Importing Food
|
|
|
| EMC
8
|
| American Industrial Hygiene Assn (AIHA)
|
| Vol #:
|
| 2
|
|
|
| EMC
9
|
| National Nutritional Foods Assn (NNFA)
|
| Vol #:
|
| 2
|
|
|
| EMC
10
|
| National Food Processors Assn (NFPA)
|
| Vol #:
|
| 2
|
|
|
| 2004N-0258
|
| Produce Safety from Production to Consumption: An Action Plan to Minimize Foodborne Illness Associated with Fresh Produce
|
|
|
| TR
1
Continued
|
| Transcript of June 29, 2004 Meeting
|
| Vol #:
|
| 2
|
|
|
| TS
1
|
| Center for Food Safety and Applied Nutrition
|
| Vol #:
|
| 1
|
|
|
| TS
2
|
| Centers for Disease Control and PRevention
|
| Vol #:
|
| 1
|
|
|
| TS
3
|
| Safe Tables Our Priority (STOP)
|
| Vol #:
|
| 1
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
| EMC 17
|
| T. Dulake
|
| Vol #:
|
| 6
|
|
|
| EMC 18
|
| C. Robson
|
| Vol #:
|
| 6
|
|
|
| EMC 19
|
| S. McGowen
|
| Vol #:
|
| 6
|
|
|
| EMC 20
|
| C. Lickteig
|
| Vol #:
|
| 6
|
|